ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.
ImmunityBio Inc Ordinary Shares -1.69%
ImmunityBio Inc Ordinary Shares IBRX | 3.49 | -1.69% |
ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.